1. Home
  2. EPRX vs CPHC Comparison

EPRX vs CPHC Comparison

Compare EPRX & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPRX
  • CPHC
  • Stock Information
  • Founded
  • EPRX 2011
  • CPHC 1994
  • Country
  • EPRX Canada
  • CPHC United States
  • Employees
  • EPRX N/A
  • CPHC N/A
  • Industry
  • EPRX
  • CPHC Services-Misc. Amusement & Recreation
  • Sector
  • EPRX
  • CPHC Consumer Discretionary
  • Exchange
  • EPRX NYSE
  • CPHC Nasdaq
  • Market Cap
  • EPRX 109.7M
  • CPHC 109.9M
  • IPO Year
  • EPRX N/A
  • CPHC 1994
  • Fundamental
  • Price
  • EPRX $3.20
  • CPHC $20.42
  • Analyst Decision
  • EPRX Strong Buy
  • CPHC
  • Analyst Count
  • EPRX 1
  • CPHC 0
  • Target Price
  • EPRX $9.00
  • CPHC N/A
  • AVG Volume (30 Days)
  • EPRX 6.9K
  • CPHC 2.7K
  • Earning Date
  • EPRX 02-07-2025
  • CPHC 03-10-2025
  • Dividend Yield
  • EPRX N/A
  • CPHC 1.37%
  • EPS Growth
  • EPRX N/A
  • CPHC N/A
  • EPS
  • EPRX N/A
  • CPHC 0.94
  • Revenue
  • EPRX N/A
  • CPHC $62,111,814.00
  • Revenue This Year
  • EPRX N/A
  • CPHC N/A
  • Revenue Next Year
  • EPRX N/A
  • CPHC N/A
  • P/E Ratio
  • EPRX N/A
  • CPHC $21.69
  • Revenue Growth
  • EPRX N/A
  • CPHC 0.13
  • 52 Week Low
  • EPRX $2.20
  • CPHC $17.10
  • 52 Week High
  • EPRX $4.08
  • CPHC $30.25
  • Technical
  • Relative Strength Index (RSI)
  • EPRX N/A
  • CPHC 46.76
  • Support Level
  • EPRX N/A
  • CPHC $20.26
  • Resistance Level
  • EPRX N/A
  • CPHC $21.10
  • Average True Range (ATR)
  • EPRX 0.00
  • CPHC 0.60
  • MACD
  • EPRX 0.00
  • CPHC -0.09
  • Stochastic Oscillator
  • EPRX 0.00
  • CPHC 7.14

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Share on Social Networks: